In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist
European Journal of PharmacologyPublished 1 June 1988
Thomas P. Blackburn, Craig W. Thornber, Robert J. Pearce, Barry Cox
Citations54
SJR quartileQ1
SJR score1.20
SNIP0.98
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The profile of ICI 169,369 should make it useful in the analysis of the role of 5-HT in physiological and pathological states and it was inactive at concentrations of either 10(-6) or 10(-5) M at receptors other than those for5-HT.
Abstract
ICI 169,369 is a chemically novel 5-HT antagonist that has higher affinity for the 5-HT2 binding sites in rat cortex than it has for 5-HT1 sites (Ki 1.79 x 10(-8) and 1.58 x 10(-6) M, respectively). In isolated tissue preparations ICI 169,369 was shown to be a competitive antagonist of 5-HT on the rabbit aorta, pig coronary artery and rat caudal artery. In the latter preparation it had a similar pA2 value to ketanserin (pA2 8.18 +/- 0.5 and 8.42 +/- 0.06, respectively). Unlike ketanserin, which was inactive, ICI 169,369 was a non-surmountable antagonist at the rat stomach fundus 5-HT 'D' receptor, recently reclassified as 5-HTIC. It was inactive (greater than 10(-6) M) at the 5-HT3 receptors found in the isolated perfused rabbit heart and the myenteric plexus of the guinea-pig ileum. At receptors other than those for 5-HT (alpha 1, alpha 2, beta 1, beta 2, H1, H2 and muscarinic), ICI 169,369 was inactive at concentrations of either 10(-6) or 10(-5) M. Thus the profile of ICI 169,369 should make it useful in the analysis of the role of 5-HT in physiological and pathological states.
Keywords
NeuroscienceBiochemistry, Genetics and Molecular Biology
British Journal of Pharmacology and ChemotherapySOME QUANTITATIVE USES OF DRUG ANTAGONISTS
3,961 Citations1959O. ARUNLAKSHANA, H. O. Schild
Molecular PharmacologyMultiple Serotonin Receptors: Differential Binding of [3H]5-Hydroxytryptamine, [3H]Lysergic Acid Diethylamide and [3H]Spiroperidol
1,354 Citations1979Stephen J. Peroutka, Solomon H. Snyder
It is proposed that [3H]5-HT and[3H]-spiroperidol label distinct populations of serotonin receptors in rat brain, designated 5-HT1 and 5- HT2 receptors, respectively.
NeuropharmacologyProposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
1,260 Citations1986Philip Bradley, G. Engel +7 more
This classification of 5-HT receptors into three main groups is based largely, but not exclusively, on data from studies in isolated peripheral tissues where definitive classification is possible, and is believed that this working classification will be relevant to functional responses to 5- HT in the central nervous system.
Life SciencesReceptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors
846 Citations1981J.E. Leysen, F. Awouters +4 more
It is concluded that R 41 468 will be a particularly suitable tool to antagonize 5-HT action mediated by5-HT2 receptors.
British Journal of Pharmacology and ChemotherapyTWO KINDS OF TRYPTAMINE RECEPTOR
843 Citations1957J. H. Gaddum, Zuleika P. Picarelli
NeuropharmacologyNeuronal 5-HT receptors in the periphery
329 Citations1984John Fozard
Comparison of relative potencies of agonists suggests similarities with the 5-HT1 recognition site of the central nervous system; no selective antagonist has yet emerged to permit their positive identification.
Journal of Cardiovascular PharmacologyPharmacology of Potent and Selective S2-Serotonergic Antagonists
117 Citations1985Paul A. J. Janssen
The different pharmacological profiles of the new S2-serotonergic antagonists and the evidence already available on their clinical effects prompt a further exploration of these agents in a large range of cardiovascular and other diseases.
European Journal of PharmacologyBlockade of serotonin receptors on autonomic neurones by (−)-cocaine and some related compounds
102 Citations1979John R. Fozard, Abu T.M. Mobarok Ali +1 more
Data indicate that (--)-cocaine and several of its derivatives inhibit 5-HT stimulation of both adrenergic and cholinergic autonomic neurones through competition with the agonist at serotonin receptor sties.
NeuropharmacologyPeripheral 5-hydroxytryptamine receptors and their classification
81 Citations1984P HUMPHREY
A critical appraisal of the literature on peripheral 5-HT receptor classification indicates that only two types have been definitively characterised, one of these appears to be the same as the 5- HT2 ligand binding site, identified in brain tissue and the other appears to have no equivalent binding site.
Naunyn-Schmiedeberg s Archives of PharmacologyEvidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery
66 Citations1983Else M�ller-Schweinitzer, G�nter Engel
It is concluded that constrictor responses to 5-HT of canine basilar artery are mediated by5-HT2-like receptors, and the agonist potencies of 8 indole derivatives and the potency of 19 recognized antagonists to inhibit constrictors' responses were established.
Journal of Pharmacology and Experimental TherapeuticsDissociation constants of serotonin agonists in the canine basilar artery correlate to Ki values at the 5-HT1A binding site.
66 Citations1986Ethan Will Taylor, Sue P. Duckles +1 more
The hypothesis that the apparent noncompetitive antagonism may be produced by slow dissociation of the antagonist-receptor complex, producing a pseudoirreversible action which is unmasked due to the lack of spare receptors is suggested.
Biochemical PharmacologyFurther evidence that vascular serotonin receptors are of the 5HT2 type
65 Citations1983Marlene L. Cohen, Norman R. Mason +2 more
Journal of Pharmacology and Experimental TherapeuticsCanine basilar artery contractions mediated by 5-hydroxytryptamine1A receptors.
52 Citations1986S J Peroutka, Sijie Huang +1 more
The 5-HT1A binding site has a pharmacological profile which, depending on the agents studied, could be significantly different from the pharmacological profiles derived from total 5- HT1 binding.
Naunyn-Schmiedeberg s Archives of PharmacologyAnalysis of the 5-hydroxytryptamine induced contraction of the human basilar arterial strip compared with the rat aortic strip in vitro
46 Citations1982Christine Förster, Eric T. Whalley
The results from this study suggest that the receptor(s) mediating 5- HT-induced contraction of the human basilar artery may be different from the classical “d-receptor” which mediates contraction to 5-HT on the rat aorta.
Brain ResearchEvidence for coexistence of serotonin and noredrenaline in sympathetic nerves supplying brain vessels of guinea pig
34 Citations1988Jing‐Yu Chang, Christer Owman +1 more
It is concluded that 5-HT is probably not synthesized in truly serotonergic fibers but rather taken up and stored together with noradrenaline in cerebrovascular sympathetic nerves originating in the superior cervical ganglia.
Journal of Pharmacology and Experimental Therapeutics5-Hydroxytryptamine receptor in rabbit aorta: characterization by butyrophenone analogs.
22 Citations1984Saul Maayani, Charles W. Wilkinson +1 more
The contractile response of isolated rabbit aorta rings to 5-hydroxytryptamine (5-HT) was antagonized by spiperone and four other butyrophenone analogs in a competitive manner, suggesting a congruence between the aortic "D" receptors and 5-HT2 type binding sites in rat brain.
Journal of Pharmacology and Experimental TherapeuticsRelationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
22 Citations1986Marlene L. Cohen, Walter E. Colbert
The contention that 5- HT receptors in the canine basilar artery are not 5-HT1 receptors as defined by ligand binding studies in brain cortical membranes is supported.
Journal of Pharmacology and Experimental TherapeuticsTemperature-dependent 5-hydroxytryptamine (5-HT)-sensitive [3H]spiperone binding to rat cortical membranes: regulation by guanine nucleotide and antidepressant treatment.
10 Citations1983Dave Kendal, Stefan R. Nahorski
Examination of the apparent affinities of the 5-HT derivatives 5-methoxytryptamine, 5,6-dihydroxytryptamine and tryptamine revealed differences in the potencies of these analogs that were particularly evident for the high affinity proportion of sites observed at 22 degrees C.